after replacing their insulin treatments with RHB and this has triggered a highly lucrative business. Health and trade ministers are refusing to take responsibility for preventing the spread of the product. The former are of the opinion that it is a food supplement, rather than a medicine, and the latter explain that it can only be forbidden from the market under health-ministry restrictions.
Source : www.lequotidiendupharmacien.fr